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Abstract
Background: In the event of amino acid starvation, the cell activates two main protective pathways: Amino Acid
starvation Response (AAR), to inhibit global translation, and autophagy, to recover the essential substrates from
degradation of redundant self-components. Whether and how AAR and autophagy (ATG) are cross-regulated and
at which point the two regulatory pathways intersect remain unknown. Here, we provide experimental evidence
that the mammalian target of rapamycin (mTOR) complex 1 (mTORC1) specifically located at the lysosome level links
the AAR with the autophagy pathway.
Methods: As an inducer of the AAR, we used halofuginone (HF), an alkaloid that binds to the prolyl-tRNA
synthetase thus mimicking the unavailability of proline (PRO). Induction of AAR was determined assessing the
phosphorylation of the eukaryotic translation initiation factor (eIF) 2α. Autophagy was monitored by assessing the
processing and accumulation of microtubule-associated protein 1 light chain 3 isoform B (LC3B) and sequestosome-1
(p62/SQSTM1) levels. The activity of mTORC1 was monitored through assessment of the phosphorylation of mTOR,
(rp)S6 and 4E-BP1. Global protein synthesis was determined by puromycin incorporation assay. mTORC1 presence
on the membrane of the lysosomes was monitored by cell fractionation and mTOR expression was determined by
immunoblotting.
Results: In three different types of human cancer cells (thyroid cancer WRO cells, ovarian cancer OAW-42 cells, and
breast cancer MCF-7 cells), HF induced both the AAR and the autophagy pathways time-dependently. In WRO cells,
which showed the strongest induction of autophagy and of AAR, global protein synthesis was little if any affected.
Consistently, 4E-BP1 and (rp)S6 were phosphorylated. Concomitantly, mTOR expression and activation declined
along with its detachment from the lysosomes and its degradation by the proteasome, and with the nuclear
translocation of transcription factor EB (TFEB), a transcription factor of many ATG genes. The extra supplementation
of proline rescued all these effects.
Conclusions: We demonstrate that the AAR and autophagy are mechanistically linked at the level of mTORC1, and
that the lysosome is the central hub of the cross-talk between these two metabolic stress responses.
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Background
Mammalian cells have developed adaptive mechanisms
to sense and counteract amino acid deprivation in order
to maintain a homeostatic intracellular pool of amino
acids [1]. According to the availability of amino acids,
mammalian cells regulate protein synthesis and autoph-
agy [2, 3]. Autophagy is a lysosomal degradation process
through which the cell eliminates the redundant or dam-
aged cytosolic material to recover the basic components
to secure the macromolecular turnover and cell homeo-
stasis. Autophagy promptly raises up when the cell is
subjected to an adverse nutrient condition, such as in
the case of amino acid deprivation [4].
A first sensor of amino acids levels is provided by the
general control nonderepressible 2 kinase (GCN2) that
detects the uncharged tRNAs resulting from the lack of
amino acids (1, 5). In this situation, GCN2 phosphory-
lates the Serine 51 of the α-subunit of eukaryotic trans-
lation initiation factor (eIF) 2α. Such phosphorylation
causes a reduction in translation initiation and protein
synthesis. Also, phosphorylated eIF2α promotes the
translation of specific mRNAs containing in their 5′
leader unique upstream open reading frames, such as
the activating transcription factor 4 (ATF4) mRNA. In
turn, ATF4 triggers the transcriptional amino acid re-
sponse pathway (AAR) by inducing the expression of
several target genes, including activating transcription
factor 3 (ATF3), CEBP homologous protein (CHOP) and
asparagines synthetase (ASNS) [1, 5–7]. Of note, recent
works indicate that the deprivation of different individ-
ual amino acids may trigger distinct AARs [1, 8].
A second sensor of amino acids levels is provided by the
mammalian target of rapamycin (mTOR) complex 1
(mTORC1). The complex includes mTOR, the 40 kDa
Pro-rich Akt substrate (PRAS40), the mammalian lethal
with SEC13 protein 8 (mLST8), the DEP domain-containing
mTOR-interacting protein (DEPTOR) and the regulatory-as-
sociated protein of mTOR (RAPTOR) [3]. When active,
mTORC1 promotes cell growth by stimulating the protein
synthesis through the phosphorylation of the eIF4E-binding
protein 1 (4E-BP1) and of p70S6 kinase 1 that in turn phos-
phorylates the ribosomal protein S6 (S6). Particularly, the
phosphorylation of Thr37/46, Thr70 and Ser65 in 4E-BP1
frees eIF4E that can then bind to eIF4G allowing the initi-
ation of cap-dependent translation.
Moreover, active mTORC1 inhibits autophagy by phos-
phorylating the autophagy-related (ATG) proteins ATG13
and Unc-51 Like Autophagy Activating Kinase 1 (ULK1).
The activity of mTORC1 is regulated by several signals,
including growth factors, cellular energy level, oxygen
level and nutrients, particularly amino acids [3, 9, 10].
Upon amino acid deprivation, mTORC1 is inactivated
with the resulting inhibition of protein synthesis and acti-
vation of autophagy. Subcellular control of mTORC1 by
amino acids levels occurs via the Rag GTPases that are
held on the membranes of the late endosomes/lysosomes
(LEL) by the Ragulator (LAMTOR) complex. In presence
of amino acids, the Rags positively regulate mTORC1 by
recruiting the complex on the LEL membranes [11, 12].
Clearly, the AAR and the autophagy processes must be
coordinated by the availability of amino acids. Whether
and how these processes are cross-regulated and at which
point the two regulatory pathways intersect remain un-
known. Here, we investigated on these issues taking ad-
vantage of the molecular mechanism of action of the
febrifugine-derivative halofuginone (HF). This drug was
reported to mimic an AAR in Th17 lymphocytes by inter-
fering with the utilization of proline [13–15]. Here, we
show that in several cancer cell lines HF induces the AAR
and concomitantly triggers the autophagy response by
promoting the proteasome-mediated degradation of
mTOR and the nuclear translocation of the autophagy
transcription factor TFEB. An excess of proline could pre-
vent all these events, proving that the unavailability of one
single (particular) amino acid can trigger both the AAR
and autophagy. Interestingly, we found that HF had a little
impact on global protein synthesis and stimulated
mTORC2 activity. Our data provide the first demonstra-
tion that the AAR and autophagy are mechanistically
linked and suggest that the therapeutic properties of HF
could be mediated by autophagy.
Methods
Reagents
Unless otherwise specified, culture media, antibiotics,
antibodies and analytical grade chemicals were from
Sigma-Aldrich Corp., St. Luis, MO, USA. Primary anti-
bodies were obtained from the following sources: rabbit
monoclonal anti-ATG7 (04–1055, EMD Millipore Cor-
poration, Billerica, MA, USA), mouse monoclonal
anti-eIF2α (2103, Cell Signaling Technology Inc., Dan-
vers, MA, USA), rabbit monoclonal anti-phospho-eIF2α
Ser 51 (3398, Cell Signaling Technology Inc.), mouse
monoclonal anti-Golgin 97 (sc-59,820, Santa Cruz Bio-
technology Inc., Dallas, TX, USA), mouse monoclonal
anti-LAMP-1 (555,798, Becton, Dickinson and Com-
pany, New Jersey, NJ, USA), rabbit polyclonal anti-LC3B
(L7543, Sigma-Aldrich Corp.), rabbit monoclonal
anti-p62/SQSTM1 (D5E2) (8025, Cell Signaling Tech-
nology Inc.), rabbit polyclonal S6 ribosomal protein
(5G10) (2217, Cell Signaling Technology Inc.), rabbit
monoclonal anti-phospho-S6 ribosomal protein (Ser235/
236) (4856, Cell Signaling Technology Inc.), rabbit
monoclonal anti-mTOR (2983, Cell Signaling Technol-
ogy Inc.), rabbit polyclonal anti-phospho-mTOR Ser
2448 (2971, Cell Signaling Technology Inc.), rabbit poly-
clonal anti-phospho-mTOR Ser 2481 (2974, Cell Signal-
ing Technology Inc.), mouse monoclonal anti-β-Tubulin
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(T5293, Sigma-Aldrich Corp.), rabbit monoclonal
anti-RAPTOR (2280, Cell Signaling Technology Inc.),
rabbit polyclonal TFEB (4240, Cell Signaling Technology
Inc.), Rabbit monoclonal anti-4E-BP1 (53H11) (9644,
Cell Signaling), Rabbit monoclonal anti-phospho-
4E-BP1 Thr 37/46 (236B4) (2855, Cell Signaling) Rabbit
polyclonal anti-phospho-Akt Ser 473 (9271, Cell Signal-
ing), Rabbit monoclonal anti-Akt (pan) (11E7) (4685,
Cell Signaling), Mouse monoclonal anti-β-actin clone
AC-15 (A5441, Sigma-Aldrich), Mouse monoclonal
anti-puromycin clone 12D10 (MABE343, Merck Milli-
pore, Darmstadt, Germany). Secondary antibodies
employed for immunoblotting were purchased from the
following sources: Horse Radish Peroxidase-conjugated
goat anti-mouse IgG (170–6516, Bio-Rad, Hercules, CA,
USA), Horse Radish Peroxidase-conjugated goat
anti-rabbit IgG (170–6515, Bio-Rad, Hercules, CA,
USA). Secondary antibodies employed for immunofluor-
escence were purchased from the following sources: IRIS
2 goat anti-rabbit IgG (2WS-08, Cyanine Technologies
S.p.A., Torino, Italy), IRIS 3 goat anti-mouse IgG
(3WS-07, Cyanine Technologies S.p.A., Torino, Italy).
Cell cultures and treatments
The following tumor-derived human cell lines available
from the ATCC (Rockville, MD, USA) were used: WRO
(thyroid carcinoma), MCF-7 (breast adenocarcinoma),
and OAW-42 (ovarian carcinoma). The cells were cul-
tured under standard conditions (37 °C, 5% CO2) in
RPMI (WRO) or Minimum Essential Medium (MCF-7
and OAW-42). Media were supplemented with 10% fetal
bovine serum (Lonza, Basel, Switzerland), 2 mM glutam-
ine and 1% penicillin-streptomycin solution. Where indi-
cated, cells were exposed to 100 nM halofuginone (HF)
in presence or absence of 10 mM ammonium chloride
(NH4
+), or 30 μM chloroquine (CQ), or 10 μM MG132,
or 35 μM cycloheximide (CHX) in complete culture
medium or Earle’s Balanced Salt Solution (EBSS) for the
indicated time. EBSS contains 1% glucose and is widely
used as a culture medium to starve the cells of amino
acids and serum growth factors (E2888). In rescue ex-
periments, extra proline was added to WRO complete
culture medium. Proline was supplied 10 times more
concentrated than the original culture medium concen-
tration (2 mM).
siRNA and plasmid transfection
siRNA and plasmid transfections were performed following
manufacturer’s protocols with Lipofectamine 2000 (Life
Technologies Ltd., Paisley, UK). Treatments were per-
formed 36 h after the transfection. siRNA sequences: con-
trol duplex siRNA 5′-AGG UAG UGU AAU CGC CUU
GTT-3′; ATG7 siRNA 5′-GGG UUA UUA CUA CAA
UGG UGT T-3′. The origin and use of the GFP-FYVE and
GFP-LC3 plasmids have been reported previously [16–18].
Immunoblotting
Cells were harvested in RIPA Buffer supplemented with
protease inhibitor cocktail, and phosphatase inhibitors
(sodium fluoride and sodium orthovanadate) and homog-
enized using an ultrasonic cell disruptor XL (Misonix,
Farmingdale, NY, US). Protein concentration was assessed
with a Bradford assay and equal amounts of protein (30 μg
of total cell homogenates) were separated by SDS-PAGE
and transferred onto PVDF membrane. After blocking
with 5% non-fat milk (Santa Cruz Biotechnology Inc.), the
filter was probed with designated primary and secondary
antibodies, developed with the enhanced chemilumines-
cence method (PerkinElmer Inc., Waltham, MA, USA).
Bands were imaged and subjected to densitometry using
the VersaDOC Imaging System apparatus (Bio-Rad)
equipped with the software Quantity One (Bio-Rad). Rep-
resentative western blotting of at least three independent
experiments are shown.
Immunofluorescence
WRO cells were plated on coverslips at 25,000 cells/cm2
and let adhere 24 h before the designated treatments.
The cells were then washed in PBS, fixed over night with
4% paraformaldehyde at 4 °C, permeabilized with 0.2%
Triton X-100 in PBS for 10 min and processed for im-
munostaining with indicated primary antibodies and cor-
responding secondary antibodies. Images were captured
with a Leica DMI6000 fluorescence microscope (Leica
Microsystems AG, Wetzlad, DE) equipped with the soft-
ware Leica Application Suite V. 3.8 (Leica Microsystems
AG). Representative images of at least three independent
experiments are shown.
Subcellular fractionation
WRO cells were cultured in presence or absence of 100
nM halofuginone for 8 h, washed twice with ice-cold
PBS and harvested in homogenization buffer (0.25M su-
crose, 2 mM Hepes Buffer, PBS) supplemented with pro-
tease inhibitor cocktail, and phosphatase inhibitors
(sodium fluoride and sodium orthovanadate). Cell sus-
pensions were homogenized using a 2ml dounce tissue
grinder and then centrifuged at 1000x g for 10 min at 4 °
C in order to obtain post-nuclear supernatants (PNS).
The PNS were loaded on 11 ml of 15 to 65% discontinu-
ous sucrose gradient prepared in homogenization buffer
and centrifuged at 20,0000x g for 16 h at 4 °C using a
SW-41 swing rotor (Beckman Coulter, Inc., Brea, CA,
USA). Twelve fractions (1 ml each) were collected from
the top of the gradient and processed for immunoblot-
ting analysis with the indicated antibodies.
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Puromycin incorporation assay
WRO cells were seeded on p35 petri at 40,000 cells/cm2
and let adhere 24 h before to perform the treatment.
After exposure to 100 nM HF in presence/absence of 2
mM proline in complete medium or incubation with
EBSS for the indicated time, the cell pellets were washed
with PBS 1X, supplemented with 5 μg/ml puromycin
(P7255, Sigma-Aldrich) and incubated at 37 °C for 10
min. The cell pellets were then washed with PBS1X and
incubated at 37 °C for 5 min. Cells were lysed in RIPA
Buffer supplemented with protease inhibitor cocktail
and phosphatase inhibitors and the homogenates used
for western blotting.
Data analysis and statistics
All data were replicated at least three times in separate ex-
periments. Densitometric analyses of immunoblot bands
were performed with Quantity One (Bio-Rad laboratories)
software. Differences between indicated protein ratios were
analyzed by Student t test. A p value ≤ of 0.05 was consid-
ered significant. Immunofluorescence intensity density was
determined with ImageJ 1.48v (http://imagej.nih.gov/ij/)
software. GraphPad Prism was employed for statistical ana-
lysis (GraphPad Software Inc.).
Results
Halofuginone induces the amino acid response pathway
in human cancer cell types
In a first set of experiments, three different types of hu-
man cancer cells, namely thyroid cancer WRO cells,
ovarian cancer OAW-42 cells, and breast cancer MCF-7
cells, were exposed to 100 nM HF and eIF2α phosphor-
ylation, chosen to monitor the induction of the AAR,
was assessed at 4, 8 and 24 h. Increased phosphorylation
of eIF2α was clearly detectable in all the cell lines starting
from 4 h of treatment with HF (Fig. 1). The level of phos-
phorylated eIF2α was differently modulated along the in-
cubation time in the three different cell lines (Fig. 1). Our
data confirm that HF induces the AAR pathway in all the
investigated cancer cell lines.
The amino acid starvation response induced by
halofuginone is paralleled by up-regulation of basal
autophagy
Next, we checked whether autophagy was induced along
with the AAR by HF. Processing and accumulation of
lipidated microtubule-associated protein 1 light chain 3
isoform B (LC3B) were assumed as an index of the
autophagosomes present in the cells [19].
A typical pattern of LC3B-I and of LC3B-II present in the
cells is shown in Fig. 2a. The conversion of LC3B-I to
LC3B-II, which is indicative of autophagosome formation
[20], increased in all cell lines upon exposure to HF (Fig. 2a,
LC3B-II/I ratio). Like for eIF2α phosphorylation, autophagy
was differently modulated in the cell lines tested during the
incubation time, likely reflecting the different genetic and
proteome background and intracellular pool of amino acids.
A significant increase of LC3B-II/I ratio was observed by 8 h
in WRO and MCF7 cells, and by 24 h in OAW-42, indicat-
ing an increase in the autophagosome formation following
exposure to HF. In the case of WRO cells, we also noted
that the chronic (24 h) exposure to HF causes some 45% cell
detachment and apoptosis (data not shown). From now on,
we chose the WRO cells as representative to investigate
more in depth the mechanisms linking the AAR with au-
tophagy, limiting the exposure to HF at 8 h to avoid
mis-interpretation due to cell toxicity.
Next, we assessed the accumulation of LCB-II in the
presence or absence of 30 μM chloroquine (CQ) by
Fig. 1 Halofuginone induces the amino acid starvation response (AAR)
pathway. Thyroid cancer WRO cells, breast cancer MCF-7 cells, and
ovarian cancer OAW-42 cells were exposed to 100 nM halofuginone
(HF) for 4, 8 and 24 h. Total and phosphorylated (Ser 51) eIF2α protein
levels were assessed by immunoblotting. As loading control, filters
were stripped and probed with anti β-Tubulin as loading control.
Representative immunoblots from three independent experiments are
shown along with P-eIF2α/eIF2α band intensity ratios as index of AAR
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immunoblotting to confirm that basal autophagy is
up-regulated following HF. Chloroquine alkalinizes the acidic
compartments, preventing the autophagosome-lysosome fu-
sion and impairing the degradation of autophagosomes and
of their content [19, 21]. Assuming the net conversion of
LC3B-I into LC3B-II (ratio LC3B-II/I) in the presence vs
absence of CQ as the relative amount of newly formed
autophagosomes (APH biogenesis), basal autophagy
was clearly up-regulated following 8 h of exposure to
HF (Fig. 2b).
We then assessed LC3B-II in WRO cells transfected
with the siRNA targeting the essential autophagy protein
Fig. 2 Halofuginone induces autophagy. a Cells were exposed to halofuginone (HF) as in Fig. 1 and LC3B protein levels were assessed by immunoblotting. As
loading control, filters were stripped and probed with ant β-Tubulin as loading control. Representative immunoblots are shown along with LC3B-II/I band
intensity ratios as index of autophagosome formation. Histograms show mean (±SD) LC3B-II/I band intensity ratios of three different experiments. Statistically
significant differences between LC3B-II/I ratios after to before HF are shown (*, p≤ 0.05). bWRO cells were exposed to halofuginone (HF) for 8 h in the
presence or in the absence of 30 μM chloroquine (CQ) and LC3B protein levels were assessed by immunoblotting. As loading control, filters were stripped and
probed with anti β-Tubulin as loading control. Representative immunoblots are shown along with LC3B-II/I band intensity ratios as index of autophagosome
formation. Relative amount of newly formed autophagosomes is expressed as LC3B-II/I ratios difference in the presence or absence of CQ (APH biogenesis).
Histograms show mean (±SD) LC3B-II/I band intensity ratios of 3 different experiments. Statistically significant differences between LC3B-II/I ratios after to before
HF are shown (*, p≤ 0.05)
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ATG7 or with the control RNA duplex to confirm that
the increase of LC3B-II following HF results from the
induction of autophagy. LC3B-II/I ratio increased upon
incubation with HF as expected, and such increase was
annulled when ATG7 was silenced (Fig. 3a).
We investigate the induction of autophagy also by
LC3B immunofluorescence in WRO cells exposed for 8
h to HF, NH4
+, or both (Fig. 3b, c). Like chloroquine,
NH4
+ prevents the autophagosome-lysosome fusion, and
impairs the degradation of autophagosomes and of their
content including the LC3B-II bound to the inner mem-
brane of the autolysosomes. Cells were stained for LC3B
that results in a punctate fluorescence corresponding to
the lipidated LC3B-II either bound to the autophago-
somes or autolysosomes, and for LAMP-1 (lysosomal as-
sociated protein-1) that labels both endosomes/
lysosomes and autolysosomes. In WRO cells exposed to
HF an increase of LC3B puncta, indicative of lipidated
LC3B either bound to the autophagosomes (in green) or
autolysosomes (in yellow) is clearly evident and suggests
the up-regulation of autophagy. Exposure to NH4
+ alone
led to the accumulation of vesicles that reflect the basal
level of autophagy. The vesicle accumulating following
NH4
+ are mainly autolysosomes (in yellow), which result
from the impairment of LC3B degradation in the
autolysosome, together with few autophagosomes (in
green), which result from the impairment of the
autophagosome-lysosomes fusion. When the cells were
exposed to HF in the presence of NH4
+ the amount of
LC3B-II only labeled (green) vesicles was even greater,
indicating that more autophagosomes not fused with ly-
sosomes were accumulating in the cells. Moreover, the
increase in yellow-labeled vesicles following NH4
+ was
greater in cells not exposed to HF, indicating a subopti-
mal fusion between autophagosome and lysosomes in
HF-treated cells. We confirmed the induction of autoph-
agy by HF in WRO cells transiently expressing either
GFP-FYVE or GFP-LC3. Transfected cells showed a
punctate GFP fluorescence following exposure to HF
that indicates the induction of autophagy and formation
of autophagosomes (Fig. 3d).
Taken together, the above data support the view that
HF has a dual-effect on the autophagy system: initially it
induces the formation of autophagosomes, and later it
slows-down their fusion with lysosomes and their
degradation.
Halofuginone, not amino acid starvation, allows protein
synthesis along with autophagy
We investigated on the functional relationship between
autophagy, AAR and global protein synthesis in the cells
exposed to HF. In a first set of experiments, we included
the conditions of amino acid and serum starvation
(EBSS), which is known to induce both AAR and
autophagy, and of mRNA translation inhibition by cyclo-
heximide (CHX), which is known to block the elong-
ation step.
The three treatments induced autophagy, as moni-
tored by the conversion of LC3B-I into LC3B-II (Fig. 4a).
As an additional marker monitoring the autophagy flux,
we determined the actual level in the cells of sequesto-
some-1 (p62/SQSTM1), which tags the autophagy sub-
strates and is degraded along with them [19]. Following
HF, p62 levels decreased of about 50 to 70% compared
to the control at 8 h (Fig. 4a). Based on p62 level, it is
evident that the three treatments also stimulated the
autophagosome degradation, besides inducing their bio-
genesis, being both these effects more prominent in
EBSS condition.
Under the same experimental conditions, we assayed
the signaling pathways governing the AAR and protein
synthesis. As shown in Fig. 4b, both HF and EBSS
promptly and strongly induced the phosphorylation of
eIF2α, which slightly declined by 8 h, while on opposite
it increased by 8 h in CHX-treated cells. These data indi-
cate that the three treatments effectively induced an
AAR. Then, we assayed the signaling pathways down-
stream mTORC1 governing protein synthesis. 4E-BP1 is
the most studied and ubiquitously expressed member of
a family of eIF4E binding proteins. Phosphorylation of
4E-BP1 at multiple sites (primed at Thr 37/46) reduces
its affinity for eIF4E that becomes free and available to
complex with eIF4G thus allowing the initiation of
cap-dependent translation. The level of phosphorylation
identifies three bands with different migratory rate, re-
spectively named from top γ (the most phosphorylated),
β (intermediate) and α (the least phosphorylated). Data
in Fig. 4b show that HF and CHX maintain the
hyper-phosphorylation of 4E-BP1 (indicated by the
prominence of the γ band) while in EBSS is detectable
only the hypo-phosphorylated isoform (α band). Next,
we looked at the phosphorylation of (rp)S6, which corre-
lates with the translational rate. We found that S6 was
phosphorylated at any time in the cells incubated with
HF while it was completely de-phosphorylated in the
cells incubated in EBSS (Fig. 4b). S6 was phosphorylated
also in the cells exposed to CHX, in which elongation of
mRNA translation is blocked.
mTOR is the catalytic subunit of two distinct com-
plexes, mTORC1 and mTORC2, that differ for compos-
ition, functionality and substrates. mTORC1 regulates,
among others, the protein synthesis and autophagy pro-
cesses, while mTORC2 phosphorylates, among other
substrates, AKT at Serine 473. To better understand the
effect of HF on mTOR-dependent protein synthesis we
incubated the cells in the presence of HF with or with-
out an excess of free proline. Rapamycin was also in-
cluded in this experiment as an inhibitor of mTORC1
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Fig. 3 (See legend on next page.)
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activity. Rapamycin effectively switched off the activity
of mTOR as indicated by phosphorylation of mTOR
(S2448) itself and of its downstream 4E-BP1 (Fig. 4c).
HF confirmed to maintain hyper-phosphorylated
4E-BP1, while slightly reducing the phosphorylation of
mTOR that was however rescued by the excess of pro-
line (Fig. 4c). Interestingly, HF stimulated the activity of
mTORC2, as testified by S473 phosphorylation of AKT,
an effect that was totally reversed by proline, while
Rapamycin did not affect mTORC2 activity as expected
(Fig. 4c). Finally, we assessed global protein synthesis in
these conditions through the puromycin incorporation
assay. Data in Fig. 4d-e suggest that HF does not impair
protein translation (or it does to a very little extent)
while EBSS largely impairs it. Taken together, these data
indicate that HF induces AAR while still allowing pro-
tein synthesis despite some inhibition of mTOR activity.
In contrast, EBSS induces AAR along with total inhib-
ition of mTOR-dependent protein synthesis.
Halofuginone effectively links the proline-deficient AAR
to autophagy
In theory, autophagy and AAR could be two un-related
processes contemporarily induced by HF. The AAR in-
duced by HF follows the inhibition of prolyl-tRNA synthe-
tase activity and can be reverted by extra supplementation
of proline [14]. We exploited this fact to prove definitively
the ability of HF to link AAR and autophagy. The supple-
mentation of standard culture medium with 2mM proline
was sufficient to rescue the activation of AAR pathway by
HF, as indicated by the restoration of the steady state levels
of eIF2α phosphorylation at 8 h (Fig. 5a). At the same time,
proline supplementation almost completely abrogated the
induction of autophagy by HF, as indicated by the level of
LC3B protein (Fig. 5a) and by the relative amounts of
LC3B-positive vesicles (green- and yellow-stained) (Fig. 5b,
c) in the cells. Interestingly, extra supplementation with the
amino acid leucine was unable to rescue the AAR induced
by HF, demonstrating the specific action of this drug in
mimicking the starvation by proline (data not shown).
From these data, we conclude that proline starvation,
as mimicked by HF, links the AAR with autophagy.
Halofuginone induces the detachment from lysosomes
and subsequent proteasome-mediated degradation of
mTOR
In the presence of amino acids, active mTORC1 is re-
cruited on the membrane of lysosomes and phosphory-
lates its substrates to promote protein synthesis and to
inhibit autophagy. Conversely, amino acid starvation re-
leases mTORC1 from the lysosome membrane and this
results in the activation of the ULK1 complex and of the
autophagy interactome [3, 22, 23]. We reasoned that to
raise up basal autophagy, HF would cause the detach-
ment of mTORC1 from the lysosomes. Thus, we
checked the abundance of mTORC1 in the lysosome
fraction of WRO cells treated for 8 h with HF. Subcellu-
lar fractions were separated by discontinuous sucrose
gradient and characterized by western blotting for or-
ganelle enrichment using LAMP-1, as a marker of lyso-
some, and Golgin-97, as a marker of the Golgi Complex.
Tubulin, a component of the cytoskeleton, was used as a
marker of the cytosolic fraction. RAPTOR, a unique
component of mTORC1, was used to discriminate
mTORC1 from mTORC2 [24, 25]. A typical pattern of
the subcellular localization of mTOR (both total and
phosphorylated at Ser 2481) and of RAPTOR is shown
in Fig. 6a. This experiment evidenced that upon treatment
with HF the abundance of mTOR and of phospho-mTOR
is greatly reduced in the lighter lysosome-containing frac-
tion 4 (possibly corresponding to unloaded small lyso-
somes). Concurrently, RAPTOR protein level decreased
only in the same fraction in which mTOR also decreased
upon HF treatment (i.e., fraction 4). Noteworthy, in un-
treated cells, fraction 4 is the one, among all the LAMP-1
positive fractions [4 to 8], containing the largest amount
of mTOR (both total and phosphorylated at Ser 2481) and
of RAPTOR (Fig. 6a). Interestingly, fractions 2 and 3,
enriched in cytoplasmic (Tubulin) and Golgi-associated
(Golgin-97) proteins and poor of lysosomes (the rela-
tive amount of LAMP-1 in these fractions is negli-
gible), are positive for mTOR and RAPTOR. It is to
be noted that the relative amount of mTORC1 pro-
teins in these fractions was not increased upon HF
treatment (Fig. 6a).
(See figure on previous page.)
Fig. 3 Halofuginone induces autophagosome formation and eventually interferes with its fusion with lysosomes. a WRO cells were transiently
transfected with ATG7 siRNA or control duplex (Ct. Du.) siRNA. After 36 h, the cells were exposed to 100 nM halofuginone (HF) for 8 h. The
expression of ATG7, LC3B and β-Tubulin was analyzed by immunoblotting of cell homogenates. Representative immunoblots are shown along
with LC3B-II/I band intensity ratios as index of autophagosome formation. b WRO cells plated on coverslips were treated with 100 nM
halofuginone (HF) in the presence or absence of 10 mM ammonium chloride (NH4
+). After 8 h the cells were fixed, processed for LC3 (green) and
LAMP-1 (red) immunostaining and imaged by fluorescence microscopy. Nuclei were stained with DAPI. Scale bars: 10 μm. c Bars indicate the
average yellow fluorescence intensity density of immunofluorescences shown in b. Data are from 5 different images for each condition. Error
bars: standard deviation. Statistically significant differences between fluorescence intensity densities before and after NH4
+ are shown (*, p≤ 0.05).
The images shown are representative of four separate experiments. d WRO cells were plated on coverslips and transiently transfected with
vectors expressing GFP-FYVE or GFP-LC3. After 36 h, the cells were exposed to 100 nM halofuginone (HF) for 8 h. Following HF, cells were imaged
by fluorescence microscopy. Scale bars: 10 μm
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Thus, upon HF treatment the mTORC1 is no more as-
sociated with (small) lysosomes though apparently it
does not relocate to the lighter subcellular fractions.
Indeed, we found that the absolute amount of mTOR
in cell homogenate and in the cytoplasmic fraction ob-
tained by differential centrifugation was reduced in the
cells treated with HF (data not shown). We thus hypoth-
esized that HF could induce the proteolysis of mTOR
soon after provoking its detachment from the lysosome.
The proteasome would be the candidate for performing
such proteolysis. We therefore assessed the protein level
of mTOR in WRO cells exposed to HF for 8 h in the
Fig. 4 Halofuginone and amino acid starvation both induce AAR yet only the former still allows mTOR-dependent protein synthesis. a, b WRO
cells were exposed for 4 and 8 h to 100 nM halofuginone (HF), 35 μM cycloheximide (CHX) or amino acid/serum growth factors deprivation
(EBSS). Thereafter, the cell homogenates were assessed for markers of autophagy (LC3B, p62) (panel a), of AAR (P-eIF2α, phosphorylated in Ser 51)
(panel b), and mTOR ability to promote protein synthesis (P-S6, phosphorylated in Ser 235/236, and P-4E-BP1, phosphorylated in Thr 37/46) (panel b).
Filters were, then stripped and probed with antibodies for total eIF2α or S6 or 4E-BP1 or β-Tubulin, as indicated. Densitometry analysis of the protein
bands for p62/Tubulin, LC3B-II/I and P-(rp)-S6/(rp)-S6 is shown. (c) WRO cells were treated with 100 nM HF, in standard medium supplemented or not
with 2mM proline (PRO), or with 100 nM rapamycin (Rap) for the time indicated. The expression of total and phosphorylated (Ser 473) Akt, total and
phosphorylated (Thr 37/46) 4E-BP1, and total and phosphorylated (Ser 2448) mTOR were assessed by immunoblotting. Filters were stripped and
probed with anti-β-Tubulin as loading control. d, e WRO cells were exposed for 4 and 8 h to 100 nM HF in presence or absence of 2mM proline (PRO)
(panel d) or incubated for 8 h in EBSS (panel e) and the presence of puromycin incorporated in neosynthesized proteins was revealed by immunoblotting
of cell homogenates. Filters were stripped and probed with anti-β-Actin as loading control. Blots shown in this Figure are representative of three
independent experiments with reproducible data
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absence or the presence of the proteasome inhibitor
MG132. As shown in Fig. 6b, the cellular amount of
mTOR protein was lower in HF-treated than in control
cells, and the concomitant treatment with MG132 pre-
vented the loss of mTOR induced by HF. These data in-
dicate that upon treatment with HF mTOR is indeed
degraded, though not completely, by the proteasome.
The excess of proline prevents the detachment of mTOR
from lysosomes and its degradation induced by
halofuginone
We have previously shown that the extra supplementa-
tion of proline could rescue the effects of HF in inducing
the AAR and autophagy. At this point, it was mandatory
to close the circle and prove that mTOR links the AAR
with autophagy, and that its degradation induced by HF
is indeed the mechanism for inducing autophagy. Thus,
the level of total and phosphorylated (active) mTOR
protein was determined by western blotting in cells ex-
posed to HF in the absence or presence of additional
proline. As shown in Fig. 7a, proline supplementation
rescued the reduction of total mTOR protein levels pro-
voked by HF. Phosphorylated mTOR at Ser 2448 and
Ser 2481 were also decreased in HF-treated cells, likely
reflecting the decreased amount of the total protein ra-
ther than a specific impairment of mTOR phosphoryl-
ation. Again, proline supplementation rescued the levels
of both phosphorylated isoforms of mTOR in the cells
co-treated with HF. We have hypothesized that upon HF
treatment mTOR is degraded soon after its detachment
from the lysosomes. We tested this hypothesis by look-
ing at the lysosomal localization of mTOR in the cells
treated with HF in the absence or presence of extra pro-
line. To this end, LAMP-1 and mTOR were identified by
immunofluorescence staining and their co-localization
assessed by fluorescence microscopy. The images in Fig. 7b
and c show a general reduction of labeled mTOR (in green)
and more specifically of mTOR co-stained with LAMP-1
(in yellow) in the cells treated with HF, which are consistent
with the detachment from lysosomes and degradation of
the protein. Noteworthy, proline supplementation rescued
the subcellular localization of mTOR at the level of the ly-
sosomes observed in not treated cells, indicating that the
excess of proline could counteract the effects of HF on
mTOR localization and degradation.
Chronic treatment with halofuginone induces the nuclear
relocation of the autophagy transcription factor TFEB
In nutrient rich conditions, lysosomal-associated mTORC1
phosphorylates the transcription factor EB (TFEB). As a re-
sult, TFEB remains sequestered in the cytoplasm and is
transcriptionally inactive. Upon activation, as in the case of
amino acid starvation, mTORC1 is released from the lyso-
somes and TFEB, not phosphorylated by mTORC1, relo-
cates to the nucleus and can initiate the transcription of
ATG genes [26]. We assessed by immunofluorescence the
Fig. 5 Excess of proline rescues the induction of AAR and of autophagy by halofuginone. a WRO cells were treated with 100 nM halofuginone
(HF) in standard medium supplemented or not with 2 mM proline (PRO) as indicated. A representative immunoblotting of P-eIF2α versus total
eIF2α (marker of AAR) and of LC3B (marker of autophagy) is shown. Densitometry analysis of the protein bands was performed and the LC3B-II/ I
band density ratios are shown. A similar pattern of protein expression was observed in two other separate experiments. b WRO cells were plated
on coverslips and treated as in (a). After 8 h the cells were fixed, processed for LC3 (green) and LAMP-1 (red) immunostaining and imaged by
fluorescence microscopy. Nuclei were stained with DAPI. Scale bars: 10 μm. c Bars indicate the average yellow fluorescence intensity density of
immunofluorescences shown in (b). Data are from five different images for each condition. Error bars: standard deviation. Statistically significant
differences between fluorescence intensity densities after to before HF, or after to before PRO in the presence of HF are shown (*, p ≤ 0.05)
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subcellular localization of TFEB in WRO cells after expos-
ure to HF. Partial relocation of TFEB from the cytosol to
the nucleus was clearly detectable when the cells were
treated with HF for 24 h (Fig. 8a, b).
Discussion
When subjected to nutrient starvation the cell activates
an array of protective responses to face the metabolic
stress. Yet, if chronically deprived of nutrient and oxy-
gen, the cell eventually succumbs despite of, or because
of, the prolonged activation of these metabolic stress re-
sponses. In particular, amino acid starvation triggers two
main stress responses: the AAR, which inhibits protein
synthesis, and autophagy, which degrades the redundant
self-structures in an attempt to provide the substrates
needed for survival. This study was designed to dissect
the cross-talk between these two metabolic stress path-
ways triggered in response to amino acid starvation. The
AAR is a pathway finalized to inhibit protein synthesis
when amino acids are not available. The first step in this
pathway is the phosphorylation of eIF2α at Serine 51 [6].
In parallel, ATF4, a transcription factor of the cAMP re-
sponse element binding protein (CREB), is synthesized
[27]. In turn, ATF4 promotes the transcription of genes
involved in biosynthesis, transport and metabolism of
amino acids, including the aminoacyl-tRNA synthetases.
Importantly, the eIF2α-ATF4 pathway has been linked to
the stress-induced expression of ATG genes [28]. Au-
tophagy is per se triggered by amino acid starvation via
the mTORC1 pathway. A complex regulatory network
modulates Rags activity, and in turn mTORC1, by sens-
ing amino acids levels in the cytosol or inside the LEL
lumen. Cytosolic proteins have been reported to be in-
volved in sensing leucine (leucyl-tRNA synthetase, LRS;
Fig. 6 Halofuginone induces the detachment of mTORC1 from the
lysosomes and partial proteasome degradation of mTOR. a WRO
cells were exposed or not to 100 nM halofuginone for 8 h and
subcellular fractions were separated by discontinuous sucrose
gradient from 15 to 55% sucrose density. Nine fractions were
collected and characterized by immunoblotting with the indicated
antibodies. A strong reduction in the content of mTOR and RAPTOR
proteins is clearly appreciable in fraction 4 of WRO cells treated with
HF. A similar trend was observed in two other independent
experiments and with diverse sucrose gradient. Post-nuclear
supernatant (PNS) and gradient loading fraction (L) were loaded as
controls. FR.N.: fraction number. b WRO cells were exposed or not to
100 nM of halofuginone (HF), or 10 μM of the proteasome inhibitor
MG132, or both. After 8 h, the cells were collected and
homogenates processed for immunoblotting to assess mTOR
protein level. As loading control, the filter was stripped and probed
with anti β-Tubulin antibody. The pattern of protein expression
shown was reproduced in three separate experiments. Densitometry
of the protein bands was performed and average mTOR/Tubulin
ratios are shown in the histogram graph. Error bars: standard
deviation. Statistically significant differences between mTOR protein
levels are shown (*, p≤ 0.05)
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Sestrin 2) [29, 30], or arginine (cellular Arginine sensor
for mTORC1, CASTOR1) [31, 32], or amino acids (cytos-
lic folliculin, FLCN; folliculin interacting protein, FNIP)
[33] levels in the cytosol and regulate Rags activity.
Transmembrane proteins have been identified to sense
alanine, proline and glycine (SLC36A1, PAT1) [34], or ar-
ginine (SLC38A9, SNAT9) [35–37], or amino acids (vacuo-
lar-adenosine triphosphatase proton pump, v-ATPase) [23]
levels inside the LEL lumen and to regulate Rags. Other
works support a model in which the LEL are not the only
subcellular hub for amino acids-dependent mTORC1 regu-
lation [10]. In fact, the transmembrane protein SLC36A4
(PAT4) has been reported to sense glutamine and serine
levels inside the trans-Golgi network lumen and to modu-
late the activity of mTORC1 localized on the Golgi mem-
branes [38].
HF has been previously reported to induce autophagy
[39–41]. In nutrient-rich conditions, HF induces autophagy
Fig. 7 AAR pathway induced by halofuginone triggers mTOR degradation. a WRO cells were exposed or not to 100 nM halofuginone (HF) in the
presence or in the absence of additional 2 mM proline (PRO). After 8 h, the cell homogenates were subjected to immunoblotting to assess total
mTOR protein level and its phosphorylation status (at Ser 2448 and Ser 2481). The same set of samples was loaded in three different gels in order
to avoid multiple stripping and re-probing of the same filter. Each filter was probed with anti β-Tubulin antibody as loading control. The pattern
of protein expression shown was reproduced in three separate experiments. Densitometry of the protein bands was performed and mTOR/
Tubulin ratios are included. b WRO cells adherent to coverslips and treated as in (a) were fixed, processed for mTOR (green) and LAMP-1 (red)
immunostaining and imaged by confocal fluorescence microscopy. Nuclei were stained with DAPI. Scale bars: 10 μm. The images shown are
representative of three separate experiments. c Bars indicate the average yellow fluorescence intensity density of immunofluorescences shown in
(b). Data are from five different images for each condition. Error bars: standard deviation. Statistically significant differences between fluorescence
intensity densities after to before HF, or after to before PRO in the presence of HF are shown (*, p≤ 0.05)
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by inactivating mTORC1 and the resulting dephosphoryla-
tion of ULK1 at Ser 757 [42]. Here, we show that mTORC1
specifically located at the lysosome level links the AAR in-
duced by HF with the autophagy pathway. More in depth,
our data show that the induction of the AAR pathway trig-
gers autophagy by promoting the detachment from the ly-
sosomes and the proteasome degradation of mTOR.
Subcellular fractionation analyses showed that it is the
lysosome-associated, not the Golgi Complex-associated
pool of mTOR that is degraded by the proteasome. On long
term, the sustained AAR and autophagy led to the nuclear
translocation of TFEB, a transcription factor of many ATG
genes. In homeostatic conditions, TFEB is stabilized in the
cytoplasm by mTORC1-mediated phosphorylation. Thus,
only when LEL-associated mTOR is extensively degraded
the pool of (un-phosphorylated) TFEB can translocate into
the nucleus and direct the synthesis of pro-autophagy genes.
As expected following the undocking of mTOR from
the lysosomes and in line with recent works [39, 41], we
observed the induction of ATG by HF in all the analyzed
cell lines. On long term sustained AAR and autophagy, as
induced by HF, led to apoptosis. It was previously reported
that the chronic up-regulation of ATF4 leads to the tran-
scription of DNA-damage- inducible transcript 3, which
in turn promotes the transcription of pro-apoptotic genes
[43]. Thus, AAR and autophagy pathways intersect at two
stages of the stress response, in the early stage to coordin-
ate the block of protein synthesis and the degradation of
the intracellular pool of protein, and in the later stage to
coordinate the programmed cell death. It remains to
Fig. 8 TFEB relocates into the nucleus upon chronic induction of AAR by HF. a WRO cells plated on coverslips were treated or not with 100 nM
halofuginone. After 8 and 24 h, the cells were fixed, processed for TFEB (green) immunostaining and imaged by confocal fluorescence microscopy.
Nuclei were stained with DAPI. Scale bars: 10 μm. The images shown are representative of three separate experiments. b Bars indicate the average
green + blue fluorescence intensity density of immunofluorescences shown in (a). Data are from five different images for each condition. Error bars:
standard deviation. Statistically significant difference between fluorescence intensity densities after to before HF is shown (*, p≤ 0.05)
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clarify whether apoptosis in HF-treated cells ensued in
spite of or because of the hyper-activation of autophagy.
Here, we used HF as a strong inducer of AAR. HF
mimics a reduced cellular pool of available proline by
competing with it for the prolyl-tRNA synthetase active
site [14]. The resulting accumulation of uncharged
tRNAPRO leads to the activation of the AAR pathway.
AAR induced by HF reached a peak at different time of
incubation in the different cell lines tested, probably
reflecting the different pool of free proline available in
the cell. HF indeed acted much alike CHX (an inhibitor
of protein synthesis) and EBSS (a condition of amino
acid and serum starvation) in inducing the AAR and
autophagy pathways. The extra supplementation of pro-
line, not of leucine (known to be a major regulator of
mTOR), rescued all the phenotypic features triggered by
HF, including the effects on mTOR degradation. Inter-
estingly, HF stimulated the phosphorylation of AKT, an
effect that was reversed by proline. We may speculate
that HF by disrupting mTORC1 from the lysosomal
membrane frees mTOR which is partly degraded by the
proteasome and partly made available to complex in
mTORC2. However, this hypothesis must be proven
experimentally.
More importantly, we found differences between HF
and amino acid starvation (EBSS) with respect to
mTOR-dependent protein synthesis control. The signal-
ing pathways governing protein synthesis and their alter-
ations in cancer cells have been the subject of recent
excellent reviews [44–46]. Briefly, in the presence of
amino acid and of active PI3K-AKT, mTORC1 can phos-
phorylate p70S6k and 4E-BP1. P70S6k will then phos-
phorylate (S235/236) S6, whose level correlates with the
rate of mRNA translation. Phosphorylation of 4E-BP1
reduces its affinity for eIF4F, which can then bind to
eIF4G and allows the initiation of translation. We found
that HF could maintain 4E-BP1 highly phosphorylated (γ
isoform), while in EBSS only α-4E-BP1 (faintly phos-
phorylated form) was apparent. This has been associated
with ongoing and repressed protein synthesis situations,
respectively. In fact, while α and β isoforms (i.e., the
least and intermediate phosphorylated forms) of 4E-BP1
associate with eIF4E, the appearance of the γ isoform
(the most phosphorylated one) reflects the release of
eIF4E [47, 48]. Notably, in EBSS the total amount of
4E-BP1 appeared reduced. It has been shown that in can-
cer cells hyper-phosphorylation of 4E-BP1 at multiple sites
plays an important role in its stabilization and overexpres-
sion [49], which may explain the higher level of the γ iso-
form observed in control and HF-treated cells. We also
found that in HF-treated, but not in EBSS-treated cells, S6
was phosphorylated, despite HF reduced to some extent
mTOR phosphorylation. Consistent with the signaling,
the puromycin incorporation assay showed that protein
synthesis was largely suppressed in the cells incubated in
EBSS while it was little if any affected when exposed to
HF in complete medium. Thus, compared to complete
starvation, HF treatment may present the advantage to
stimulate the removal of potentially dangerous material by
autophagy while allowing protein synthesis. In other
words, HF permits the recycling of the basic components
resulting from the degradation of autophagic cargo in new
essential cellular constituents, while this process is pre-
cluded during starvation. The effects seen with HF resem-
ble those reported for resveratrol (RV), a nutraceuticals
that acts as a protein restriction mimetic [50, 51]. In a separ-
ate work, we have shown that culturing ovarian cancer cells
in complete medium containing RV or in EBSS inhibited
protein synthesis, as indicated by down-phosphorylation of
mTOR and of its downstream target eIF4E-binding
protein 1 (4E-BP1) and of S6 and concomitant hyper-
phosphorylation of eIF2α, while inducing autophagy
in parallel [51]. However, EBSS was more effective in
inhibiting protein synthesis while RV was more effect-
ive in inducing autophagy [51]. In a recent study, Xia
and colleagues have shown that HF-induced autoph-
agy suppresses MCF-7 migration and invasion by
down-regulating STMN1 and p53, indicating that
HF-induced autophagy may play an important role in
the anti-cancer effect of HF [41]. Intriguingly, RV too
was shown to suppress the migration of ovarian can-
cer cells by raising the level of autophagy [52].
HF is a racemic halogenated derivate of febrifugine, an
alkaloid extract of the plant Blue Evergreen Hydrangea
(Dichroa febrifuga Lour) known for its antiprotozoal ac-
tivity and used as antimalarial remedy in traditional
Chinese medicine [14, 53]. The mechanism of its antimalar-
ial property remains obscure. Our data suggest that this
property is related to its effects on the autophagy-lysosome
system. The lysosome is an indispensable station for the
maturation cycle of the plasmodium, and drugs able to buf-
fer the acidity in the lysosome, such as chloroquine, dis-
rupts this cycle. Chloroquine is now known to also impair
the last step of the autophagy process. Here, we found that
HF initially induces autophagosome formation and later
impairs the autophagosome-lysosome fusion step, much
alike chloroquine. Of note, our work is the first to show a
dual-effect of HF on autophagy as the other studies investi-
gating HF-induced autophagy reported only the induction
of autophagy by the HF and not an impairment of the
autophagosome-lysosome fusion step [39, 41]. We
hypothesize that the effect of HF on the autophagosome-
lysosome fusion step may differ depending on the cell line,
HF concentration and incubation time. More investigation
is needed to clarify the effect of HF on the autophagosome-
lysosome fusion step since in this work we focused only on
short term incubation time to avoid mis-interpretation due
to cell toxicity. HF elicits also a general anti-inflammatory
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response by inhibiting the differentiation of inflammatory
Th17 cells, and this effect was clearly sue to the induction
of the AAR [13–15]. HF is currently employed in clinical
trials due to its therapeutic potential in fibrotic diseases and
cancer [42, 54–59] (https://clinicaltrials.gov/). The data here
reported strongly support the view that the therapeutic po-
tential of HF is linked to its ability to induce autophagy,
and eventually cell death, besides its modulatory effect on
protein synthesis.
Conclusions
The cartoon shown in Fig. 9 summarizes the main find-
ings reported in this study. Overall, our data demonstrate
that the AAR and autophagy are mechanistically linked by
mTORC1, and that the lysosome is the central hub of the
cross-talk between these two metabolic stress responses.
Our results also suggest that the therapeutic potential of
HF is linked to its ability to trigger autophagy.
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